Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Prostate Cancer

Free Subscription Articles published in Radiology Retrieve available abstracts of 47 articles: HTML format

Single Articles

July 2022
1. LEE GH, Chatterjee A, Karademir I, Engelmann R, et al
   Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
   Radiology. 2022 Jul 26:211895. doi: 10.1148/radiol.211895.
   PubMed     Abstract available
   
   
   
2. ZUKOTYNSKI KA, Kuo PH
   (18)F-DCFPyL PET/CT in Men with Prostate Cancer.
   Radiology. 2022 Jul 19:221536. doi: 10.1148/radiol.221536.
   PubMed    
   
   
   
3. ULANER GA, Thomsen B, Bassett J, Torrey R, et al
   (18)F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation.
   Radiology. 2022 Jul 19:220218. doi: 10.1148/radiol.220218.
   PubMed     Abstract available
   
   
   
4. GHAI S, Perlis N, Atallah C, Jokhu S, et al
   Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
   Radiology. 2022 Jul 19:212163. doi: 10.1148/radiol.212163.
   PubMed     Abstract available
   
   
   May 2022
5. JADVAR H
   Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.
   Radiology. 2022 May 24:221074. doi: 10.1148/radiol.221074.
   PubMed    
   
   
   
6. BASSO DIAS A, Finelli A, Bauman G, Veit-Haibach P, et al
   Impact of (18)F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.
   Radiology. 2022 May 24:211836. doi: 10.1148/radiol.211836.
   PubMed     Abstract available
   
   
   
7. HAIDER MA
   It's Time for a Standardized MRI Assessment Scheme for Prostate Cancer Recurrence.
   Radiology. 2022 May 10:220701. doi: 10.1148/radiol.220701.
   PubMed    
   
   
   
8. PECORARO M, Turkbey BI, Purysko AS, Girometti R, et al
   Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
   Radiology. 2022 May 10:212252. doi: 10.1148/radiol.212252.
   PubMed     Abstract available
   
   
   March 2022
9. WU D, Jiang K, Li H, Zhang Z, et al
   Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer.
   Radiology. 2022 Mar 8:211180. doi: 10.1148/radiol.211180.
   PubMed     Abstract available
   
   
   
10. CHATTERJEE A, Oto A
    Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI.
    Radiology. 2022 Mar 8:220056. doi: 10.1148/radiol.220056.
    PubMed    
    
    
    February 2022
11. KUMAR R, Singh SK, Mittal BR, Vadi SK, et al
    Safety and Diagnostic Yield of (68)Ga Prostate-specific Membrane Antigen PET/CT Guided Robotic-assisted Transgluteal Prostatic Biopsy.
    Radiology. 2022 Feb 22:204066. doi: 10.1148/radiol.204066.
    PubMed     Abstract available
    
    
    
12. UEDA T, Ohno Y, Yamamoto K, Murayama K, et al
    Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging.
    Radiology. 2022 Feb 1:204097. doi: 10.1148/radiol.204097.
    PubMed     Abstract available
    
    
    January 2022
13. CIVELEK AC
    Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of (18)F-DCFPyL PET/CT.
    Radiology. 2022 Jan 25:212993. doi: 10.1148/radiol.212993.
    PubMed    
    
    
    
14. METSER U, Zukotynski K, Mak V, Langer D, et al
    Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2022 Jan 25:211824. doi: 10.1148/radiol.211824.
    PubMed     Abstract available
    
    
    
15. RANASINGHE WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, et al
    Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.
    Radiology. 2022 Jan 25:204732. doi: 10.1148/radiol.204732.
    PubMed     Abstract available
    
    
    
16. LAMBERG H, Shankar PR, Singh K, Caoili EM, et al
    Preoperative Prostate MRI Predictors of Urinary Continence Following Radical Prostatectomy.
    Radiology. 2022 Jan 18:210500. doi: 10.1148/radiol.210500.
    PubMed     Abstract available
    
    
    
17. KANAS AF, Fenelon SS, Santos JMMM, Coelho RF, et al
    Case 297: Mucinous Adenocarcinoma of the Prostate.
    Radiology. 2022;302:238-242.
    PubMed     Abstract available
    
    
    December 2021
18. GOTTLIEB RH
    Introducing a Standard in Prostate Cancer Imaging Evaluation.
    Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.
    PubMed    
    
    
    
19. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
    Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
    Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
    PubMed     Abstract available
    
    
    November 2021
20. CHATTERJEE A, Mercado C, Bourne RM, Yousuf A, et al
    Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings.
    Radiology. 2021 Nov 9:204459. doi: 10.1148/radiol.2021204459.
    PubMed     Abstract available
    
    
    
21. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021;301:E418.
    PubMed    
    
    
    October 2021
22. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021;301:E380.
    PubMed    
    
    
    August 2021
23. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021 Aug 31:211837. doi: 10.1148/radiol.2021211837.
    PubMed    
    
    
    
24. MARGEL D, Bernstine H, Groshar D, Ber Y, et al
    Diagnostic Performance of (68)Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2021 Aug 31:204093. doi: 10.1148/radiol.2021204093.
    PubMed     Abstract available
    
    
    July 2021
25. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021 Jul 13:204321. doi: 10.1148/radiol.2021204321.
    PubMed     Abstract available
    
    
    May 2021
26. DENIFFEL D, Healy GM, Dong X, Ghai S, et al
    Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112.
    PubMed     Abstract available
    
    
    
27. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021;299:E259.
    PubMed    
    
    
    
28. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021;299:E258.
    PubMed    
    
    
    
29. GOLDBERG SN
    More Interventional Oncologic Fire from COLDFIRE-2.
    Radiology. 2021;299:481-482.
    PubMed    
    
    
    April 2021
30. HARMON SA, Gesztes W, Young D, Mehralivand S, et al
    Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Radiology. 2021 Apr 13:202425. doi: 10.1148/radiol.2021202425.
    PubMed     Abstract available
    
    
    
31. COSTA DN
    Multiparametric MRI of the Prostate: Beyond Cancer Detection and Staging.
    Radiology. 2021 Apr 13:204506. doi: 10.1148/radiol.2021204506.
    PubMed    
    
    
    March 2021
32. JADVAR H
    Competitive Advantage of PSMA Theranostics in Prostate Cancer.
    Radiology. 2021 Mar 30:210348. doi: 10.1148/radiol.2021210348.
    PubMed    
    
    
    
33. LAWHN-HEATH C, Salavati A, Behr SC, Rowe SP, et al
    Prostate-specific Membrane Antigen PET in Prostate Cancer.
    Radiology. 2021 Mar 30:202771. doi: 10.1148/radiol.2021202771.
    PubMed     Abstract available
    
    
    
34. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021 Mar 9:201852. doi: 10.1148/radiol.2021201852.
    PubMed     Abstract available
    
    
    February 2021
35. TEMPANY-AFDHAL CMC
    Focal Treatment of Prostate Cancer: MRI Helps Guide the Way Forward.
    Radiology. 2021 Feb 2:204333. doi: 10.1148/radiol.2021204333.
    PubMed    
    
    
    
36. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021 Feb 2:202717. doi: 10.1148/radiol.2021202717.
    PubMed     Abstract available
    
    
    
37. TEMPANY-AFDHAL CMC, Padhani A, Barentsz J, Weinreb J, et al
    Perspectives and Concerns about PI-RADS and Variability.
    Radiology. 2021;298:E112.
    PubMed    
    
    
    November 2020
38. BAZARGANI S, Bandyk M, Balaji KC
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
    Radiology. 2020 Nov 3:202870. doi: 10.1148/radiol.2020202870.
    PubMed    
    
    
    July 2020
39. ZUKOTYNSKI KA, Rowe SP
    Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI in Biochemically Recurrent Prostate Cancer.
    Radiology. 2020 Jul 7:202098. doi: 10.1148/radiol.2020202098.
    PubMed    
    
    
    
40. LINDENBERG L, Mena E, Turkbey B, Shih JH, et al
    Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI.
    Radiology. 2020 Jul 7:192018. doi: 10.1148/radiol.2020192018.
    PubMed     Abstract available
    
    
    
41. MILOT L
    Variation of PI-RADS Interpretations between Experts: A Significant Limitation.
    Radiology. 2020;296:85-86.
    PubMed    
    
    
    June 2020
42. ZHANG Z, Wu HH, Priester A, Magyar C, et al
    Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology.
    Radiology. 2020 Jun 9:192330. doi: 10.1148/radiol.2020192330.
    PubMed     Abstract available
    
    
    May 2020
43. TAN N, Oyoyo U, Bavadian N, Ferguson N, et al
    PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
    Radiology. 2020 May 12:191689. doi: 10.1148/radiol.2020191689.
    PubMed     Abstract available
    
    
    
44. PADHANI AR, Petralia G
    Radiologists Should Integrate Clinical Risk Factors with MRI Findings for Meaningful Prostate Cancer Staging.
    Radiology. 2020 May 5:201082. doi: 10.1148/radiol.2020201082.
    PubMed    
    
    
    
45. PARK KJ, Kim MH, Kim JK
    Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Radiology. 2020 May 5:192133. doi: 10.1148/radiol.2020192133.
    PubMed     Abstract available
    
    
    April 2020
46. WESTPHALEN AC, McCulloch CE, Anaokar JM, Arora S, et al
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
    Radiology. 2020 Apr 21:190646. doi: 10.1148/radiol.2020190646.
    PubMed     Abstract available
    
    
    
47. MEYRIGNAC O, Aziza R, Roumiguie M, Malavaud B, et al
    Closing the Gap between Prostate Cancer and Deep Learning Detection Tools.
    Radiology. 2020 Apr 14:200187. doi: 10.1148/radiol.2020200187.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: